CRO Services
As your Contract Research Organization, OXON helps plan and implement the generation of Real-World evidence for safety, market access/HEOR and drug development.
KNOW MORELate-phase studies
We help pharmaceutical, biotech and medical device companies to cost-effectively meet the requirements of late-phase clinical studies for better outcomes or greater value.
KNOW MORETherapeutic Areas
OXON offers proven experience and a large portfolio of studies in all major therapy areas, including orphan conditions, pregnancy, and risk minimization.
KNOW MOREReal World Evidence and Late-Phase Research
OXON has been selected as a preferred provider by several big pharma companies.
With strong links to EMA and world-renowned academics and institutions in Europe and Asia for studies and teaching, OXON offers proven experience and a large portfolio of studies in all major therapeutic areas.
OXON conducts:
• Primary data studies: prospective, registries, retrospective chart review, cross-sectional, surveys and pragmatic trials
• Secondary data studies: electronic records and registries
• Hybrid studies, including external controls for orphan medicines
• Synthesis research: systematic review and aggregate and IPD meta-analysis and landscaping
• Data analysis, modelling and simulation
Contributing to Cardiovascular Research: OXON Epidemiology at the 21st CVCT Forum
OXON Epidemiology at the 21st Global CVCT Forum December 9-11, 2024 | Washington, DC OXON Epidemiology will be participating in the 21st Global CardioVascular Clinical Trialists Forum (CVCT), taking place[…]
Read more
White Paper: Breakthroughs in Upper Gastrointestinal Tumours – Insights from ESMO 2024
Breakthroughs in Upper Gastrointestinal Tumours – Insights from ESMO 2024. White Paper based on late-breaking abstracts presented in Barcelona. Upper gastrointestinal (GI) tumours, including hepatocellular carcinoma (HCC), gastric cancer, and[…]
Read more
OXON’s RWE services and innovations at CTS 2024
OXON at CTS sharing a new method to boost trial and RWE study efficiency November 28-29, 2024 | Barcelona OXON will support CTS 2024 as an exhibitor, showcasing expanded services[…]
Read moreWe strive our best to support our clients in conducting cost-efficient observational studies worldwide
We pulled together
professionals and resources
to serve you better
READ MORELet us help design and conduct your optimal PASS or Outcomes observational study
OXON IS YOUR RWE OBSERVATIONAL STUDIES SERVICE PROVIDER
OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, >600 papers (100+ NEJM/Lancets)
REQUEST A MEETINGWe are a partner centre of the ENCePP scientific network, which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the EU PAS Register, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies